Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Laeknabladid ; 96(4): 259-64, 2010 04.
Article in Icelandic | MEDLINE | ID: mdl-20339165

ABSTRACT

OBJECTIVE: To assess the prevalence of obesity and the association with smoking and education among young Icelandic women residing within and outside the capital area. MATERIALS AND METHODS: A self-administered questionnaire was sent to 28.000 Icelandic women, 18-45 years-old, in the period November 2004 to June 2005. The sample was randomly selected from The National Registry, response rate being 54.6%. The study was part of a large Nordic population-based cross-sectional study. Logistic regression was used for assessing the odds ratio of obesity (BMI > or = 30) in a multivariate analysis according to smoking and education, taking also into account age and alcohol consumption. The chi-square test was used for comparing percentages. RESULTS: Thirteen percent of women residing in the capital area were obese compared with 21% outside the capital. In the multivariate analysis obesity was increased among women living outside the capital (OR = 1.66; 95% CI 1,50-1,83), among smokers (OR=1,13; 95% CI 1.01-1.28), and among women who did not have university education (OR=1.53; 95%CI 1.36-1.71). Daily smokers within the capital area were more likely to be obese (OR=1.27; 95%CI 1.07-1.49) but not smokers outside the capital (OR=1.0). . CONCLUSIONS: Residence outside the capital area, daily smoking and non-university education are associated with an increased risk of obesity among young Icelandic women. The relationship between these factors is complex and differs between women residing within and outside the capital area.


Subject(s)
Educational Status , Obesity/epidemiology , Residence Characteristics , Rural Population , Smoking/epidemiology , Urban Population , Women's Health , Adolescent , Adult , Chi-Square Distribution , Cross-Sectional Studies , Female , Health Surveys , Humans , Iceland/epidemiology , Logistic Models , Middle Aged , Obesity/etiology , Odds Ratio , Prevalence , Risk Assessment , Risk Factors , Smoking/adverse effects , Surveys and Questionnaires , Young Adult
2.
Acta Obstet Gynecol Scand ; 88(1): 27-35, 2009.
Article in English | MEDLINE | ID: mdl-19031282

ABSTRACT

OBJECTIVE: Evaluate the efficacy of catch-up HPV vaccination in sexually active young women and the potential impact of HPV vaccines on the practice of organized screening. SAMPLE: (1) Women enrolled in the Future II study and (2) from a separate population-based study in Iceland. METHODS: (1) Analysis of cytological and histological results and colposcopic examinations among 710 women, aged 18-23, with less than five sexual partners, irrespectively of baseline HPV status at enrolment. (2) The impact on screening practice as determined by evaluating the distribution of 12 oncogenic HPV types in 582 cervical intraepithelial lesions (CIN 2-3) and cancer cases. MAIN OUTCOME MEASURES: (1) Distribution of evaluated parameters according to age at enrolment. (2) Age distribution of four HPV groups, within age classes and HPV groups: mean time to development of lesions, mean time to development of CIN 2-3+, cumulative frequency for CIN 2-3+ lesions after the last normal smear. RESULTS: (1) After an average 52 months of post-enrolment follow-up, significant reductions in all evaluated parameters were observed in women aged 18-19 at enrolment. (2) Among women <25 years, the proportion of cases with only HPV 16/18 was significantly lower and the proportion containing HPV16/18 plus > or =1 out of 10 non-vaccine HPV types (31/33/45/52/58/35/39/51/56/59) was higher than at age 25-49. The proportion of cases containing only the non-vaccine types was the same within all age groups. Cases with HPV 16/18 and some non-vaccine types decreased significantly with age and accumulated more slowly after the last negative smear. CONCLUSIONS: Catch-up vaccination of younger women should be considered in the context of sexual practices and the effects of prevalent disease on observed vaccine efficacy. Current data do not support a change in the lower age limit or screening intervals for women.


Subject(s)
Human papillomavirus 16/immunology , Human papillomavirus 18/immunology , Mass Screening/organization & administration , Papillomavirus Infections/prevention & control , Papillomavirus Vaccines/administration & dosage , Uterine Cervical Dysplasia/prevention & control , Uterine Cervical Neoplasms/prevention & control , Adolescent , Age Distribution , Colposcopy , Female , Follow-Up Studies , Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 , Humans , Iceland , Incidence , Probability , Risk Assessment , Sensitivity and Specificity , Sexual Behavior , Sexual Partners , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/virology , Vaccination/methods , Vaginal Smears , Young Adult , Uterine Cervical Dysplasia/pathology , Uterine Cervical Dysplasia/virology
SELECTION OF CITATIONS
SEARCH DETAIL